Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flavell, K J
Right arrow Articles by Murray, P G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flavell, K J
Right arrow Articles by Murray, P G
J Clin Pathol: Mol Pathol 2000; 53:262-269
© 2000 Journal of Clinical Pathology


Review

Hodgkin's disease and the Epstein-Barr virus

K J Flavell2 and P G Murray1

1 The School of Health Sciences, University of Wolverhampton, Wolverhampton WV1 1DJ, UK
2 The Department of Pathology, Division of Cancer Studies, Medical School, University of Birmingham, Birmingham B15 2TT, UK

Correspondence: Dr Murray p.g.murray{at}bham.ac.uk

Hodgkin's disease is an unusual cancer because the malignant cells constitute only a minority of the total tumour mass and, as a consequence, the study of these cells has been a major challenge. Recently, the application of newer technologies, such as single cell polymerase chain reaction (PCR) and gene expression array analysis, to the study of Hodgkin's disease have yielded new insights into the pathogenesis of this tumour. In addition, the recognition that a proportion of Hodgkin's disease tumours harbour the Epstein-Barr virus (EBV) and that its genome is monoclonal in these tumours suggests that the virus contributes to the development of Hodgkin's disease in some cases. This review summarises current knowledge of the pathogenesis of Hodgkin's disease with particular emphasis on the association with EBV. J Clin Pathol: Mol Pathol

Key Words: Hodgkin's disease • Epstein-Barr virus • Hodgkin-Reed Sternberg cells




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Niens, A. van den Berg, A. Diepstra, I. M. Nolte, G. van der Steege, A. Gallagher, G. M. Taylor, R. F. Jarrett, S. Poppema, and G. J. te Meerman
The Human Leukocyte Antigen Class I Region Is Associated with EBV-Positive Hodgkin's Lymphoma: HLA-A and HLA Complex Group 9 Are Putative Candidate Genes.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2280 - 2284.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. D. Lemke, J. S. Haynes, R. Spaete, D. Adolphson, A. Vorwald, K. Lager, and J. E. Butler
Lymphoid Hyperplasia Resulting in Immune Dysregulation Is Caused by Porcine Reproductive and Respiratory Syndrome Virus Infection in Neonatal Pigs
J. Immunol., February 1, 2004; 172(3): 1916 - 1925.
[Abstract] [Full Text]


Home page
Mol. Pathol.Home page
P G Murray and L S Young
Themed issue: the biology and pathology of the Epstein-Barr virus
Mol. Pathol., October 1, 2000; 53(5): 219 - 221.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.